Chengzhi Holding Faces 6.6 Billion Yuan Goodwill Overhang as Investors Press on Impairment Risks

Earnings
โดย 读创财经·Read original
Summary · why it matters

Chengzhi Holding addressed investor concerns over its high goodwill and earnings volatility during an earnings briefing. As of the end of 2025, the company's goodwill on the books stood at 6.694 billion yuan, accounting for about 24.08 percent of total assets. Of this, the original goodwill value for Nanjing Chengzhi Clean Energy alone reached 6.569 billion yuan. The company said it conducts impairment tests at the end of each year. In 2025, only Yunnan Hanmeng Pharmaceutical had a goodwill impairment provision of 34.5832 million yuan, and that project's goodwill has been fully provided for. No impairment was booked for the Nanjing Chengzhi and Shijiazhuang Chengzhi Yonghua goodwill items. In 2025, the company swung to a net loss attributable to shareholders of minus 78.1427 million yuan. In the first quarter of 2026, net profit attributable to shareholders was 233 million yuan, up 177.38 percent year on year, but second-quarter profit performance may be far below the first quarter. The company attributed this to fluctuations in raw material and product prices.

Impact on stocks 1

Others▼ · 1 stocks
Chengzhi Shareholding Co Ltd
000990
▼ NegativeCapitalrelevance

High goodwill of 6.694 billion yuan and swing to net loss in 2025 raise impairment risk, though Q1 2026 profit improved.

Off-coverage companies 3

南京诚志清洁能源有限公司Private▼ Negative
Capitalrelevance

Nanjing Chengzhi Clean Energy carries 6.569 billion yuan in goodwill, a key impairment risk despite no impairment booked in 2025.

Shijiazhuang Chengzhi YonghuaPrivate▼ Negative
Capitalrelevance

Shijiazhuang Chengzhi Yonghua goodwill item had no impairment in 2025 but remains a risk given overall goodwill overhang.

云南汉盟制药有限公司Private▼ Negative
Capitalrelevance

Yunnan Hanmeng Pharmaceutical had a goodwill impairment provision of 34.58 million yuan, fully provided for.

© 2026 MarketDXNews